The combination creates a context where AOD 9604s lipolytic effect is occurring simultaneously with GH-stimulated protein synthesis and recovery, theoretically allowing fat loss and lean mass preservation to happen in parallel
Long-term safety data is limited for many peptides
Administration Guide AOD-9604 is administered via subcutaneous injection, the same method used for insulin and many other peptide therapies
For further reading on related peptide protocols and research applications, explore our guides on:
Similarly, individuals who have undergone intestinal surgery, including weight loss surgery, are also at higher risk
Users report improved recovery, better sleep quality, and maintained muscle mass during injury periods